These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease. Hussein N, Weng SF, Kai J, Kleijnen J, Qureshi N. Cochrane Database Syst Rev; 2015 Aug 12; 2015(8):CD010849. PubMed ID: 26264938 [Abstract] [Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P. Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557 [Abstract] [Full Text] [Related]
5. Zinc supplements for treating thalassaemia and sickle cell disease. Swe KM, Abas AB, Bhardwaj A, Barua A, Nair NS. Cochrane Database Syst Rev; 2013 Jun 28; 2013(6):CD009415. PubMed ID: 23807756 [Abstract] [Full Text] [Related]
6. Assessing ethnicity in preconception counseling: genetics--what nurse practitioners need to know. Edwards QT, Seibert D, Macri C, Covington C, Tilghman J. J Am Acad Nurse Pract; 2004 Nov 28; 16(11):472-80. PubMed ID: 15617360 [Abstract] [Full Text] [Related]
7. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing. Wilson RD, De Bie I, Armour CM, Brown RN, Campagnolo C, Carroll JC, Okun N, Nelson T, Zwingerman R, Audibert F, Brock JA, Brown RN, Campagnolo C, Carroll JC, De Bie I, Johnson JA, Okun N, Pastruck M, Vallée-Pouliot K, Wilson RD, Zwingerman R, Armour C, Chitayat D, De Bie I, Fernandez S, Kim R, Lavoie J, Leonard N, Nelson T, Taylor S, Van Allen M, Van Karnebeek C. J Obstet Gynaecol Can; 2016 Aug 28; 38(8):742-762.e3. PubMed ID: 27638987 [Abstract] [Full Text] [Related]
8. Blood transfusions for treating acute chest syndrome in people with sickle cell disease. Dolatkhah R, Dastgiri S. Cochrane Database Syst Rev; 2020 Jan 16; 1(1):CD007843. PubMed ID: 31942751 [Abstract] [Full Text] [Related]
9. Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY. Kronn D, Jansen V, Ostrer H. Arch Intern Med; 1998 Apr 13; 158(7):777-81. PubMed ID: 9554684 [Abstract] [Full Text] [Related]
10. Treatment of dental complications in sickle cell disease. Mulimani P, Ballas SK, Abas AB, Karanth L. Cochrane Database Syst Rev; 2019 Dec 16; 12(12):CD011633. PubMed ID: 31841224 [Abstract] [Full Text] [Related]
11. Treatment of dental and orthodontic complications in thalassaemia. Mulimani P, Abas AB, Karanth L, Colombatti R, Kulkarni P. Cochrane Database Syst Rev; 2023 Feb 02; 2(2):CD012969. PubMed ID: 36732291 [Abstract] [Full Text] [Related]
12. Treatment of dental and orthodontic complications in thalassaemia. Mulimani P, Abas AB, Karanth L, Colombatti R, Kulkarni P. Cochrane Database Syst Rev; 2019 Aug 02; 8(8):CD012969. PubMed ID: 31425614 [Abstract] [Full Text] [Related]
13. Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG). Gregg AR, Aarabi M, Klugman S, Leach NT, Bashford MT, Goldwaser T, Chen E, Sparks TN, Reddi HV, Rajkovic A, Dungan JS, ACMG Professional Practice and Guidelines Committee. Genet Med; 2021 Oct 02; 23(10):1793-1806. PubMed ID: 34285390 [Abstract] [Full Text] [Related]
14. Carrier Screening Programs for Cystic Fibrosis, Fragile X Syndrome, Hemoglobinopathies and Thalassemia, and Spinal Muscular Atrophy: A Health Technology Assessment. Ontario Health (Quality) . Ont Health Technol Assess Ser; 2023 Oct 02; 23(4):1-398. PubMed ID: 37637488 [Abstract] [Full Text] [Related]
15. Interventions for promoting participation in shared decision-making for children and adolescents with cystic fibrosis. Malone H, Biggar S, Javadpour S, Edworthy Z, Sheaf G, Coyne I. Cochrane Database Syst Rev; 2019 May 23; 5(5):CD012578. PubMed ID: 31119726 [Abstract] [Full Text] [Related]
16. The future of Cochrane Neonatal. Soll RF, Ovelman C, McGuire W. Early Hum Dev; 2020 Nov 23; 150():105191. PubMed ID: 33036834 [Abstract] [Full Text] [Related]
17. Blood transfusions for treating acute chest syndrome in people with sickle cell disease. Dastgiri S, Dolatkhah R. Cochrane Database Syst Rev; 2016 Aug 30; (8):CD007843. PubMed ID: 27574910 [Abstract] [Full Text] [Related]
18. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia. Osborne SR, Alston LV, Bolton KA, Whelan J, Reeve E, Wong Shee A, Browne J, Walker T, Versace VL, Allender S, Nichols M, Backholer K, Goodwin N, Lewis S, Dalton H, Prael G, Curtin M, Brooks R, Verdon S, Crockett J, Hodgins G, Walsh S, Lyle DM, Thompson SC, Browne LJ, Knight S, Pit SW, Jones M, Gillam MH, Leach MJ, Gonzalez-Chica DA, Muyambi K, Eshetie T, Tran K, May E, Lieschke G, Parker V, Smith A, Hayes C, Dunlop AJ, Rajappa H, White R, Oakley P, Holliday S. Med J Aust; 2020 Dec 30; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144 [Abstract] [Full Text] [Related]
19. Disclosing to parents newborn carrier status identified by routine blood spot screening. Oliver S, Dezateux C, Kavanagh J, Lempert T, Stewart R. Cochrane Database Syst Rev; 2004 Oct 18; 2004(4):CD003859. PubMed ID: 15495068 [Abstract] [Full Text] [Related]
20. Antibiotics for treating osteomyelitis in people with sickle cell disease. Martí-Carvajal AJ, Agreda-Pérez LH. Cochrane Database Syst Rev; 2016 Nov 14; 11(11):CD007175. PubMed ID: 27841931 [Abstract] [Full Text] [Related] Page: [Next] [New Search]